Automated cell therapy manufacturing platform that integrates closed processing, parallel patient batches, and electronic records within Cellares’ development and manufacturing services.

Development services translate partners’ existing cell therapy manufacturing processes onto Cell Shuttle while evaluating critical quality attributes and analytical comparability.

Consulting services help cell therapy developers plan global regulatory strategies, prepare submissions, and coordinate manufacturing and analytical documentation.

Automated quality control platform that prepares samples, runs cell therapy assays, and records results using integrated laboratory instruments.

Contract cell therapy manufacturing services use Cellares’ automated platforms and Smart Factories to support clinical supply and commercial production.

Analytical development services transfer partners’ manual quality control workflows onto Cell Q, evaluating assay comparability and preparing automated testing for regulatory review.